(Bloomberg) — U.S. stock index futures rose as reports related to coronavirus treatments and corporate acquisitions supported investor sentiment ahead of the Federal Reserve’s policy meeting this week.December contracts on the S&P 500 gained 1.2% as of 6:25 a.m. in London after the University of Oxford and AstraZeneca Plc restarted a U.K. trial of a Covid-19 vaccine, while Pfizer Inc. Chief Executive Officer Albert Bourla said it’s “likely” the U.S. will deploy a treatment to the public before year-end. Separately, Gilead Sciences Inc. agreed to acquire Immunomedics Inc.Futures on the Nasdaq 100 Index climbed 1.4% after Nvidia Corp. said it …read more
Source:: Yahoo Finance
